Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.736% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CN(Cc1cnn(-c2ccc(F)cc2)c1)Cc1nc(Cc2ccccc2)no1
b COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1)CC2
c Cc1nc2sc(-c3ccccc3)nn2c(=O)c1Br
Answer: c. Cc1nc2sc(-c3ccccc3)nn2c(=O)c1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2sc(-c3ccccc3)nn2c(=O)c1Br
Cc1nc2sc(-c3ccccc3)nn2c(=O)c1Br
6-bromo-7-methyl-2-phenyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one